Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Diabetes Research and Clinical Practice|October 15, 2016
Interleukin-18 gene polymorphism and risk of CVD in older patients with type 2 diabetes mellitusMonika Buraczynska, Katarzyna Ksiazek, Pawel Zukowski, et al.Immunological Investigations|November 29, 2017
Interleukin-4 Gene Intron 3 VNTR Polymorphism in Type 2 Diabetes Patients with Peripheral NeuropathyMonika Buraczynska, Kinga Buraczynska, Pawel Zukowski, et al.Diabetes Research and Clinical Practice|June 21, 2016
The effect of Toll-like receptor 4 gene polymorphism on vascular complications in type 2 diabetes patientsMonika Buraczynska, Pawel Zukowski, Katarzyna Ksiazek, et al.Journal of Diabetes and Its Complications|June 29, 2014
Polymorphism in microRNA-196a2 contributes to the risk of cardiovascular disease in type 2 diabetes patientsMonika Buraczynska, Pawel Zukowski, Piotr Wacinski, et al.Journal of Diabetes and Its Complications|October 1, 2013
Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetesMonika Buraczynska, Piotr Wacinski, Pawel Zukowski, et al.Neuromolecular Medicine|October 4, 2011
Renalase gene polymorphisms in patients with type 2 diabetes, hypertension and strokeMonika Buraczynska, Pawel Zukowski, Kinga Buraczynska, et al.Cytokine|December 26, 2015
Effect of G(-174)C polymorphism in interleukin-6 gene on cardiovascular disease in type 2 diabetes patientsMonika Buraczynska, Pawel Zukowski, Bartlomiej Drop, et al.Clinical Immunology (Orlando, Fla.)|May 12, 2009
Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patientsMonika Buraczynska, Piotr Ksiazek, Pawel Zukowski, et al.Molecular Biology Reports|February 28, 2014
Transcription factor 7-like 2 (TCF7L2) gene polymorphism and clinical phenotype in end-stage renal disease patientsMonika Buraczynska, Pawel Zukowski, Piotr Ksiazek, et al.Human Immunology|June 12, 2010
Complement receptor 1 gene polymorphism and cardiovascular disease in dialyzed end-stage renal disease patientsMonika Buraczynska, Piotr Ksiazek, Piotr Wacinski, et al.Pageof 2